Human Psychopharmacology-Clinical and Experimental

Papers
(The TQCC of Human Psychopharmacology-Clinical and Experimental is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)
ArticleCitations
Issue Information27
Issue Information24
Elevated serum levels of TNF‐α, IL‐6, and IL‐18 in chronic methamphetamine users19
Issue Information17
Could improved recognition and treatment of anxiety disorders lead to a reduction in suicide?17
16
Issue Information14
‘Nico’—A lone voyager in Strange Seas13
J Guy Edwards, FRCPsych, FRCP, FRCGP (Hon), DPM, HonMFPH, Founding Editor of Human Psychopharmacology12
Issue Information12
Trajectories of sentiment in 11,816 psychoactive narratives12
12
The type 2 diabetes mellitus susceptibility gene CDKAL1 polymorphism is associated with depressive symptom in first‐episode drug‐naive schizophrenic patients11
The use of antipsychotics in obsessive compulsive disorder10
Comparative evaluation of craving, sleep quality, sexual function and quality of life in opioid use disorder patients in remission with buprenorphine/naloxone maintenance treatment9
The prevalence of constipation in adult psychiatric out‐patients on clozapine treatment at a regional public hospital in Hong Kong8
Peripheral edema associated with antidepressant use: Systematic review of case reports7
Patient outcome following selective serotonin reuptake inhibitor prescribing in primary care in Wales (UK)7
Efficacy of amisulpride for depressive symptoms in individuals with mental disorders: A systematic review and meta‐analysis7
7
Clinical predictors of depressive symptom remission and response after racemic ketamine and esketamine infusion in treatment‐resistant depression7
Ayahuasca may help to improve self‐compassion and self‐criticism capacities6
5
Analysis of schizophrenia‐associated genetic markers in the HLA region as risk factors for tardive dyskinesia5
Acute Administration of 10 mg Methylphenidate on Cognitive Performance and Visual Scanning in Healthy Adults: Randomised, Double‐Blind, Placebo‐Controlled Study5
Effect of fasedienol (PH94B) pherine nasal spray and steroidal hormones on electrogram responses and autonomic nervous system activity in healthy adult volunteers5
Efficacy of the nootropic supplement Mind Lab Pro on memory in adults: Double blind, placebo‐controlled study4
4
Issue Information4
Inflammatory markers at baseline correlate with subsequent clinical response to quetiapine in patients with bipolar disorder4
Co‐ingestion of prescription drugs and alcohol in US adults aged 50 years or older4
Efficacy and safety of lemborexant as an alternative drug for patients with insomnia taking gamma‐aminobutyric acid–benzodiazepine receptor agonists or suvorexant4
Corrigendum4
5‐MeO‐DMT has not been found in traditional ayahuasca preparations and the combination of 5‐MeO‐DMT with MAOIs is dangerous3
Initiation of psychotropic medication in hospitalized patients with COVID‐19: Association with clinical and biological characteristics3
Experience and views of healthcare professionals towards people who use new psychoactive substances: Evidence from statutory, non‐statutory, and private mental health and addiction healthcare services3
Comparison of naltrexone implant and oral buprenorphine‐naloxone in the treatment of opiate use disorder3
3
Serotonin transporter availability, neurocognitive function and their correlation in abstinent 3,4‐methylenedioxymethamphetamine users3
3
Hypothalamic‐pituitary‐adrenal and autonomic response to psychological stress in abstinent alcohol use disorder individuals with and without depressive symptomatology3
0.044801950454712